甘氨双唑钠放疗增敏治疗肿瘤的临床研究

Clinical research of glycididazole(CMNa) with radiotherapy to increase tumor sensitization treatment

目的:评价甘氨双唑钠(CMNa)联合放疗治疗肿瘤的近期疗效及毒副作用。方法:对30例肿瘤患者采取甘氨双唑钠联合放疗与采取普通放疗的30例病例进行比较。结果:增敏放疗组完全缓解21例(70%),普通放疗组完全缓解13例(43.33%)。毒副作用未见明显差异。结论:增敏放疗组近期疗效优于普通放疗组,且毒副作用未见明显增加。

Objective： To evaluate the immediate efficacy and toxic effects of CMNa combing with radiotherapy in treatment of tumors. Methods： 30 cases of tumor patients undergone CMNa with radiotherapy treatment were compared with those 30 cases who only received routine radiotherapy for examining the results. Results： Patients in sensitization group got a complete relief rate of 70% （21 cases） while there was only 43.33% in routine radiotherapy group（ 13 cases）. There showed no difference in toxic effects in both group. Conclusion： Immediate efficacy of CMNa combing with radiotherapy can outweigh simple radiotherapy.